Search research articles
Contact Us
Filters
Showing results (421-430 of 644) with videos related to
Page
of 65
Sort By:
Nuclear Medicine and Biology
|
April 25, 2000
Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studies
A A Morales, J Ducongé, D Alvarez-Ruiz, et al.
Plos One
|
October 16, 2010
Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids
Diego M Presman, Lautaro D Alvarez, Valeria Levi, et al.
Gene Therapy
|
November 5, 2004
Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy
M Breidenbach, D T Rein, M Everts, et al.
Gynecologic Oncology
|
December 7, 2007
Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines
T Michael Numnum, Sharmila Makhija, Baogen Lu, et al.
Breast Cancer (Dove Medical Press)
|
February 20, 2016
Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer
Tineke Casneuf, Amy E Axel, Peter King, et al.
Journal of Hazardous Materials
|
September 8, 2012
Automatic dosage of hydrogen peroxide in solar photo-Fenton plants: development of a control strategy for efficiency enhancement
E Ortega-Gómez, J C Moreno Úbeda, J D Alvarez Hervás, et al.
Enfermeria Intensiva
|
July 1, 1997
[Validation in Spain of the dysfunctional ventilatory response to weaning]
A Giménez, I Fernández-Reyes, B Marín, et al.
Gene Therapy
|
March 5, 2004
Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy
H Wu, T Han, J T Lam, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo
|
October 1, 1983
[Intestinal perforation by a phytobezoar after vagectomy and pyloroplasty]
D Alvarez Ruiz de Viñaspre, A Alvarez Ruiz de Viñaspre, D Cabezon Sáenz, et al.
Gynecologic Oncology
|
April 9, 2014
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study
Ronald D Alvarez, Michael W Sill, Susan A Davidson, et al.
Page
of 65
Search research articles
Search
Showing results (421-430 of 644) with videos related to
Sort By:
Page
of 65
Nuclear Medicine and Biology
|
April 25, 2000
Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studies
A A Morales, J Ducongé, D Alvarez-Ruiz, et al.
Plos One
|
October 16, 2010
Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids
Diego M Presman, Lautaro D Alvarez, Valeria Levi, et al.
Gene Therapy
|
November 5, 2004
Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy
M Breidenbach, D T Rein, M Everts, et al.
Gynecologic Oncology
|
December 7, 2007
Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines
T Michael Numnum, Sharmila Makhija, Baogen Lu, et al.
Breast Cancer (Dove Medical Press)
|
February 20, 2016
Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer
Tineke Casneuf, Amy E Axel, Peter King, et al.
Journal of Hazardous Materials
|
September 8, 2012
Automatic dosage of hydrogen peroxide in solar photo-Fenton plants: development of a control strategy for efficiency enhancement
E Ortega-Gómez, J C Moreno Úbeda, J D Alvarez Hervás, et al.
Enfermeria Intensiva
|
July 1, 1997
[Validation in Spain of the dysfunctional ventilatory response to weaning]
A Giménez, I Fernández-Reyes, B Marín, et al.
Gene Therapy
|
March 5, 2004
Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy
H Wu, T Han, J T Lam, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo
|
October 1, 1983
[Intestinal perforation by a phytobezoar after vagectomy and pyloroplasty]
D Alvarez Ruiz de Viñaspre, A Alvarez Ruiz de Viñaspre, D Cabezon Sáenz, et al.
Gynecologic Oncology
|
April 9, 2014
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study
Ronald D Alvarez, Michael W Sill, Susan A Davidson, et al.
Page
of 65